Why Are Pharma Companies Investing in Insurance Claims Data & Real-World Data?
From MEDDDICAL podcasts
Show by MEDDDICAL
Discover how insurance claims data is transforming pharma and medtech by accelerating clinical trials, enhancing post-market surveillance, and unlocking smarter market access strategies. But working through the complex real-world evidence field requires the right expertise and partnerships. Learn more at https://medddical.com
More episodes of MEDDDICAL podcasts
More episodes
- Half the Story Was Always Missing: What Real-World Patient Data Changes Now
- Phenotype Validation in Real-World Data: Why It Makes or Breaks Your Study
- Longitudinal RWE in Pharma: What Makes a Dataset Fit for Purpose?
- What It Takes to Build Predictive Models That Actually Work
- Real-World Pharma Data: How It's Reshaping Modern Drug Development
- AI Synthetic Health Data: What Works for Pharma & What Doesn't
- How AI-Powered RWE Is Cutting Drug Costs & Accelerating Development
- Claims Data or EHR? How to Choose the Right Source for Your Study
- Which German Claims Data Route Is Right for Pharma? FDZ vs. Commercial Providers
- AI In RWE: How Choosing The Wrong Dataset Can Result In Clinical Disasters
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.